logo

For the Inventor, By the Inventor

New Haven, CT, United States of America

Aeromics, Inc.

USPTO Granted Patents = 16



Forward Citations = 102

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Paul Robert Mcguirk (16 out of 16 patents)

silverMedal George William Farr (13 out of 13 patents)

bronzeMedal Marc F Pelletier (13 out of 13 patents)

4.  Robert J Zamboni (7 out of 39 patents)

5.  Christopher H Hall (5 out of 5 patents)

6.  Walter F Boron (5 out of 6 patents)

7.  John Colucci (4 out of 23 patents)

8.  Helmi Zaghdane (4 out of 7 patents)

9.  Stephan D Parent (3 out of 52 patents)

10.  Melanie Janelle Bevill (3 out of 21 patents)

11.  Steven Williams (1 out of 1 patent)

12.  Robert Zamboni (0 patent)

13.  John Colucci (0 patent)

14.  Helmi Zaghdane (0 patent)


16 patents:

1. 12503425 - Methods of treating or controlling cytotoxic cerebral edema (2025-12-23),
2. 12496308 - Methods of administering a pharmaceutically acceptable salt of 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate (2025-12-16),
3. 12213987 - Prodrug salts (2025-02-04),
4. 12091431 - Crystals (2024-09-17),
5. 11873266 - Methods of treating or controlling cytotoxic cerebral edema consequent to an ischemic stroke (2024-01-16),
6. 11801254 - Pharmaceutical compositions and methods of making pharmaceutical compositions comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate (2023-10-31),
7. 11725018 - Crystals (2023-08-15),
8. 11117909 - Crystals (2021-09-14),
9. 11084778 - Methods of treating cardiac edema, neuromyelitis optica, and hyponatremia (2021-08-10),
10. 11071744 - Prodrug salts (2021-07-27),
11. 10894055 - Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}4-chlorophenyl dihydrogen phosphate (2021-01-19),
12. 10258636 - Prodrug salts (2019-04-16),
13. 9994514 - Methods of treating cerebral edema and spinal cord edema (2018-06-12),
14. 9949991 - Methods of treating aquaporin-mediated conditions (2018-04-24),
15. 9827253 - Prodrug salts (2017-11-28),
Company Overview
Aeromics, Inc. is a biotechnology company based in New Haven, Connecticut, specializing in the development of innovative therapeutic solutions. The organization focuses on leveraging advanced technologies to create novel drug candidates aimed at addressing unmet medical needs. Aeromics is particularly engaged in research related to protein engineering and drug delivery systems, striving to enhance treatment efficacy and patient outcomes in various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Aeromics, Inc. USPTO Patent Assignee Logo
16 Patents

#19 in New Haven, CT

#459 in Connecticut

#19,935 in US

#37,868 in the World

New Haven, CT (US)
New Haven, CT, United States of America

Aeromics, Inc.

Forward Citations = 102

11 inventors:

goldMedal Paul Robert Mcguirk (16 out of 16 patents)

silverMedal George William Farr (13 out of 13 patents)

bronzeMedal Marc F Pelletier (13 out of 13 patents)

4.  Robert J Zamboni (7 out of 39 patents)

5.  Christopher H Hall (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aeromics, Inc.. Retrieved from https://idiyas.com/company/aeromics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…